As many of you know we are continuing our advocacy (albeit virtually) with the Congress, EU and others. We wanted to bring to your attention, IAMERS latest efforts to advocate for greater access to service access information. Read more about our efforts here.
April 29, 2020 An editorial by Robert J. Kerwin Originally publish on DOTMed Health Care Business NewsWith a big tip of the hat to Captain Obvious, our hospitals and health delivery organizations are heroically dealing with a terrible pandemic the likes of which we have no real comparison for in our lifetime. As Healthcare Business News [...]
Here are some of our members enjoying Madrid.Download
GE chairman and CEO Larry Culp said in light of its just-announced deal with Danaher, the IPO for its healthcare division may be delayed. Read more here.
Cuts of up to $112 million in Medicare ultrasound reimbursements have organizations like the American College of Radiology calling for radiologists to clarify the actual costs of purchasing and servicing ultrasound equipment. Read more here.
Read more here. “Nowhere in the white paper does MITA provide support for its claim of an increased "risk to the public health." As MITA once acknowledged in its previous submission to the FDA it is impossible to provide a statistically valid analysis of the extent of problems.”
While current FDA standards regulate the remanufacturing of medical devices, regulation of servicing is not a requirement. In addition, few safeguards exist to prevent the crossover of servicing activity with that of remanufacturing, creating increased risks to public health, the safety of patients and providers who use the technology. These risks are elaborated on in [...]
“Despite organizations’ large investments in security, email fraud continues to rise,” the report authors wrote. “Cybercriminals are growing more advanced. And attacks are evading traditional security tools, leaving people as the last line of defense.” Read more here.
Medical imaging technologies and machine learning will support a new generation of tools that can personalize treatments and improve outcomes for patients. Read more here.
CEO Larry Culp acknowledged as much in a post-earnings conference call, stating, “We expect to monetize just up to under 50 percent of our health-care business,” adding that the unit “continues to prepare for public company separation, and that is progressing very well," Read more here.